142 related articles for article (PubMed ID: 22941486)
1. Erythrocyte-mediated delivery of pravastatin: in vitro study of effect of hypotonic lysis on biochemical parameters and loading efficiency.
Harisa GI; Ibrahim MF; Alanazi FK
Arch Pharm Res; 2012 Aug; 35(8):1431-9. PubMed ID: 22941486
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human erythrocytes as potential carrier for pravastatin: an in vitro study.
Harisa Gel-D; Ibrahim MF; Alanazi FK
Int J Med Sci; 2011 Mar; 8(3):222-30. PubMed ID: 21448309
[TBL] [Abstract][Full Text] [Related]
3. Study of the factors influencing the encapsulation of zidovudine in rat erythrocytes.
Briones E; Colino CI; Lanao JM
Int J Pharm; 2010 Nov; 401(1-2):41-6. PubMed ID: 20854886
[TBL] [Abstract][Full Text] [Related]
4. Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study.
Alanazi FK; Harisa Gel-D; Maqboul A; Abdel-Hamid M; Neau SH; Alsarra IA
Arch Pharm Res; 2011 Apr; 34(4):563-71. PubMed ID: 21544721
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation and in vitro evaluation of amikacin-loaded erythrocytes.
Millán CG; Castañeda AZ; López FG; Marinero ML; Lanao JM; Arévalo M
Drug Deliv; 2005; 12(6):409-16. PubMed ID: 16253957
[TBL] [Abstract][Full Text] [Related]
6. Pravastatin provides antioxidant activity and protection of erythrocytes loaded Primaquine.
Alanazi F
Int J Med Sci; 2010 Oct; 7(6):358-65. PubMed ID: 21060723
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b.
Hamidi M; Zarrin AH; Foroozesh M; Zarei N; Mohammadi-Samani S
Int J Pharm; 2007 Aug; 341(1-2):125-33. PubMed ID: 17512685
[TBL] [Abstract][Full Text] [Related]
8. In vitro studies of amikacin-loaded human carrier erythrocytes.
Gutiérrez Millán C; Bax BE; Castañeda AZ; Marinero ML; Lanao JM
Transl Res; 2008 Aug; 152(2):59-66. PubMed ID: 18674740
[TBL] [Abstract][Full Text] [Related]
9. Isolation of hemoglobin from bovine erythrocytes by controlled hemolysis in the membrane bioreactor.
Stojanović R; Ilić V; Manojlović V; Bugarski D; Dević M; Bugarski B
Appl Biochem Biotechnol; 2012 Mar; 166(6):1491-506. PubMed ID: 22252906
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro characterization of carrier erythrocytes for vaccine delivery.
Hamidi M; Zarei N; Zarrin AH; Mohammadi-Samani S
Int J Pharm; 2007 Jun; 338(1-2):70-8. PubMed ID: 17317049
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis.
Gutiérrez Millán C; Zarzuelo Castañeda A; Sayalero Marinero ML; Lanao JM
Blood Cells Mol Dis; 2004; 33(2):132-40. PubMed ID: 15315791
[TBL] [Abstract][Full Text] [Related]
12. Human erythrocytes as drug carriers: loading efficiency and side effects of hypotonic dialysis, chlorpromazine treatment and fusion with liposomes.
Favretto ME; Cluitmans JC; Bosman GJ; Brock R
J Control Release; 2013 Sep; 170(3):343-51. PubMed ID: 23747798
[TBL] [Abstract][Full Text] [Related]
13. [The comparison in vitro the effects of pravastatin and quercetin on the selected structural parameters of membrane erythrocytes from patients with hypercholesterolemia].
Broncel M; Franiak I; Koter-Michalak M; Duchnowicz P; Chojnowska-Jezierska J
Pol Merkur Lekarski; 2007 Feb; 22(128):112-6. PubMed ID: 17598654
[TBL] [Abstract][Full Text] [Related]
14. The in vitro hemolytic effect of diltiazem on erythrocytes exposed to varying osmolarity.
Watts TJ
Toxicol Mech Methods; 2010 Oct; 20(8):435-9. PubMed ID: 20486888
[TBL] [Abstract][Full Text] [Related]
15. Erythrocytes as carrier for prednisolone: in vitro and in vivo evaluation.
Shavi GV; Doijad RC; Deshpande PB; Manvi FV; Meka SR; Udupa N; Omprakash R; Dhirendra K
Pak J Pharm Sci; 2010 Apr; 23(2):194-200. PubMed ID: 20363699
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in-vitro characterization of tramadol-loaded carrier erythrocytes for long-term intravenous delivery.
Foroozesh M; Hamidi M; Zarrin A; Mohammadi-Samani S; Montaseri H
J Pharm Pharmacol; 2011 Mar; 63(3):322-32. PubMed ID: 21749379
[TBL] [Abstract][Full Text] [Related]
17. Resealing of erythrocyte membranes after hypotonic hemolysis.
Kanda S; Inoue K; Nojima S
Jpn J Exp Med; 1979 Aug; 49(4):251-6. PubMed ID: 502081
[TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of human intact erythrocytes loaded by enalaprilat.
Hamidi M; Tajerzadeh H; Dehpour AR; Rouini MR; Ejtemaee-Mehr S
Drug Deliv; 2001; 8(4):223-30. PubMed ID: 11757780
[TBL] [Abstract][Full Text] [Related]
19. Cell volume and osmotic properties of erythrocytes after complement lysis measured by flow cytometry.
Bauer J; Valet G
J Immunol; 1983 Feb; 130(2):839-44. PubMed ID: 6848597
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of hypotonic preswelling method for encapsulation of enalaprilat in intact human erythrocytes.
Tajerzadeh H; Hamidi M
Drug Dev Ind Pharm; 2000 Dec; 26(12):1247-57. PubMed ID: 11147125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
